2010 Annual Meeting Brochure
Ereshefsky to Close 2010 Annual Meeting with Cutting-Edge Session
Larry Ereshefsky, PharmD, FCCP, BCPP presents the closing keynote address at the 2010 Annual Meeting on the topic of Strategies to Develop Disease Modifying Drugs. Focusing on Alzheimer’s disease and surrogate endpoints, Dr. Ereshefsky will analyze the current state of the art for disease modifying drugs with focus on research design methodologies, biosurrogate markers and case illustrations in the area of Alzheimer’s disease. You can hear more about this impactful, closing session from Dr. Ereshefsky himself by viewing the provided video. Don’t miss this cutting-edge session from this internationally recognized expert and crowd favorite, Dr. Larry Ereshefsky.